Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04176926 · ClinicalTrials.gov registry record
Validation of Software for Assessment of Atrial Fibrillation From Data Acquired by a Wearable Smartwatch
A clinical trial, sponsored by Fitbit.
- Completed
- Registry status
- 472
- Enrollment target
NCT04176926 is a clinical trial that has completed, run by Fitbit. The registered enrollment target is 472 participants.
The verdict
NCT04176926 has completed, sponsored by Fitbit.
- COMPLETED
- Registry status
- 472 participants
- Enrollment target
Study Summary
The goal of this study is to validate the Fitbit ECG software algorithm's ability to detect atrial fibrillation using data derived from a Fitbit wrist-worn consumer device that features a single lead ECG. The performance of the software application will be measured against centralized Core Lab physician-adjudicated 12-lead ECG tracings from FDA cleared ECG monitors as reference standards. The Fitbit software is intended as a pre-screening technology. It should identify candidates who may benefit from further evaluation. The software is not intended to be a diagnostic system.
Interventions
- DIAGNOSTIC_TEST Electrocardiogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 472 participants |
| Start Date | 2019-10-29 |
| Est. Completion | 2020-03-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04176926
The ClinicalTrials.gov registry entry for NCT04176926 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 472 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fitbit, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electrocardiogram is the first listed.
NCT04176926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04176926 about?
NCT04176926 is a clinical study titled "Validation of Software for Assessment of Atrial Fibrillation From Data Acquired by a Wearable Smartwatch". The goal of this study is to validate the Fitbit ECG software algorithm's ability to detect atrial fibrillation using data derived from a Fitbit wrist-worn consumer device that features a single lead ECG. The performance of the software application will be measured against centralized Core Lab physi...
What is the current status of trial NCT04176926?
This trial is currently completed. The enrollment target is 472 participants. The study started on 2019-10-29. Estimated completion is 2020-03-02.
What interventions are being tested in trial NCT04176926?
The interventions under investigation include: Electrocardiogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04176926?
This trial is sponsored by Fitbit, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.